According to Novavax's latest financial reports the company's total debt is S$0.29 Billion. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2024-12-31 | S$0.31 B | 3.52% |
2023-12-31 | S$0.30 B | -58.95% |
2022-12-31 | S$0.73 B | 20.09% |
2021-12-31 | S$0.61 B | -0.86% |
2020-12-31 | S$0.61 B | 42.67% |
2019-12-31 | S$0.43 B | -0.48% |
2018-12-31 | S$0.43 B | 2.6% |
2017-12-31 | S$0.42 B | -7.17% |
2016-12-31 | S$0.45 B | 81841.15% |
2015-12-31 | S$0.55 M | -57.63% |
2014-12-31 | S$1.31 M | -44.67% |
2013-12-31 | S$2.38 M | 61.73% |
2012-12-31 | S$1.47 M | 255.58% |
2011-12-31 | S$0.41 M | -19.57% |
2010-12-31 | S$0.51 M | -24.48% |
2009-12-31 | S$0.68 M | -97.92% |
2008-12-31 | S$32.76 M | 0.08% |
2007-12-31 | S$32.73 M | -7.94% |
2006-12-31 | S$35.55 M | -30.05% |
2005-12-31 | S$50.83 M | -16.16% |
2004-12-31 | S$60.62 M | -15.37% |
2003-12-31 | S$71.63 M | -0.28% |
2002-12-31 | S$71.84 M | 13.02% |
2001-12-31 | S$63.56 M | 83.38% |
2000-12-31 | S$34.66 M | 20718.62% |
1999-12-31 | S$0.16 M |
Company | Total debt/th> | differencediff. | Country |
---|---|---|---|
![]() Agenus
AGEN | S$0.11 B | -59.75% | ๐บ๐ธ USA |
![]() Sarepta Therapeutics
SRPT | S$1.73 B | 487.67% | ๐บ๐ธ USA |
![]() Emergent BioSolutions
EBS | S$0.85 B | 191.13% | ๐บ๐ธ USA |
![]() BioCryst Pharmaceuticals
BCRX | S$1.02 B | 247.67% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | S$40.29 B | 13,585.88% | ๐ฌ๐ง UK |
![]() Pfizer PFE | S$78.91 B | 26,704.54% | ๐บ๐ธ USA |
![]() Novartis NVS | S$40.26 B | 13,575.39% | ๐จ๐ญ Switzerland |
![]() NanoViricides NNVC | S$1.93 M | -99.34% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | S$30.66 B | 10,315.42% | ๐ฌ๐ง UK |
![]() Celldex Therapeutics CLDX | S$4.41 M | -98.50% | ๐บ๐ธ USA |